Literature DB >> 7711948

Betahistine dihydrochloride treatment facilitates vestibular compensation in the cat.

B Tighilet1, J Leonard, M Lacour.   

Abstract

Unilateral lesion of the vestibular system induces posturo-locomotor deficits that are compensated for with time. Drug therapy is currently used to improve the recovery process and to facilitate vestibular compensation. Betahistine dihydrochloride is an histamine-like substance that has been employed in vestibular pathology; it was found effective in many forms of vertigo and in vestibular-related syndromes. Investigations performed in animal models have shown betahistine-induced neuronal modulations in the vestibular nuclei complex and interactions with the H1 and H3 histamine receptors. Potentially, this substance is therefore capable to interfere with some recovery mechanisms and to improve the behavioral adaptations. But there is at present a total lack of data concerning the influence of betahistine treatment on vestibular compensation in animal models. The aim of this study was to understand the pharmacological activity of betahistine in the restoration of posture and locomotor balance functions in unilateral vestibular neurectomized cats. Posture recovery was assessed by quantifying the surface reaction of the cat's support as measured while standing erect on its four legs, at rest. Locomotor balance recovery was determined using the rotating beam test, by measuring the maximal performance (max. P.) of the cat and its locomotion speed regulation during the postoperative time period. We have compared the recovery profile and time course of these static (posture) and dynamic (equilibrium) functions in three groups of cats. Two experimental groups were treated at daily doses of 50 mg/kg and 100 mg/kg, respectively. Betahistine dihydrochloride was given orally until complete recovery of posturolocomotor functions. One untreated control group served as the reference. Results showed that postoperative treatment strongly accelerated the recovery process in both treated groups, inducing a time benefit of around 2 weeks as compared to the controls. Maximum performance of the cats on the rotating beam as well as locomotion speed regulation were highly correlated to the postoperative development of the cat's support surface, indicating that compensation of the static vestibulospinal deficits conditioned the subsequent locomotor balance recovery. These behavioral data showed that betahistine dihydrochloride constitutes a useful drug therapy for the symptomatic treatment of central vestibular disorders in our animal model of unilateral vestibular lesion. Improvement of vestibular compensation under betahistine postoperative treatment, as evidenced here for the posture and locomotor balance functions, is discussed both in terms of aspecific effect (histamine-induced increase of the level of vigilance) or more direct action in the vestibular nuclei (histamine-induced rebalance of neuronal activity on both sides).

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7711948

Source DB:  PubMed          Journal:  J Vestib Res        ISSN: 0957-4271            Impact factor:   2.435


  19 in total

1.  GABA(A) receptor agonist and antagonist alter vestibular compensation and different steps of reactive neurogenesis in deafferented vestibular nuclei of adult cats.

Authors:  Sophie Dutheil; Guy Escoffier; Ali Gharbi; Isabelle Watabe; Brahim Tighilet
Journal:  J Neurosci       Date:  2013-09-25       Impact factor: 6.167

2.  Rote of adaptation exercises in clinical practice.

Authors:  M V Kirtane
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  1999-04

Review 3.  Menière's disease: pathophysiology and treatment.

Authors:  H Thai-Van; M J Bounaix; B Fraysse
Journal:  Drugs       Date:  2001       Impact factor: 9.546

Review 4.  [Special ginkgo extract in cases of vertigo: a systematic review of randomised, double-blind, placebo controlled clinical examinations].

Authors:  K-F Hamann
Journal:  HNO       Date:  2007-04       Impact factor: 1.284

5.  Histaminergic and glycinergic modulation of GABA release in the vestibular nuclei of normal and labyrinthectomised rats.

Authors:  Filip Bergquist; Alasdair Ruthven; Mike Ludwig; Mayank B Dutia
Journal:  J Physiol       Date:  2006-10-12       Impact factor: 5.182

Review 6.  Histamine and betahistine in the treatment of vertigo: elucidation of mechanisms of action.

Authors:  M Lacour; O Sterkers
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

7.  Changes in the histaminergic system during vestibular compensation in the cat.

Authors:  Brahim Tighilet; Suzanne Trottier; Christiane Mourre; Michel Lacour
Journal:  J Physiol       Date:  2006-04-13       Impact factor: 5.182

8.  Betahistine in the treatment of vertiginous syndromes: a meta-analysis.

Authors:  C Della Pepa; G Guidetti; M Eandi
Journal:  Acta Otorhinolaryngol Ital       Date:  2006-08       Impact factor: 2.124

Review 9.  Antivertigo medications and drug-induced vertigo. A pharmacological review.

Authors:  O Rascol; T C Hain; C Brefel; M Benazet; M Clanet; J L Montastruc
Journal:  Drugs       Date:  1995-11       Impact factor: 9.546

10.  Management of acute vertigo with betahistine.

Authors:  R A Bradoo; N K Nerurkar; J B Mhapankar; S F Patil; D G Kute
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2000-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.